127 related articles for article (PubMed ID: 24053766)
1. Prospective analysis of penile length changes after radical prostatectomy.
Berookhim BM; Nelson CJ; Kunzel B; Mulhall JP; Narus JB
BJU Int; 2014 May; 113(5b):E131-6. PubMed ID: 24053766
[TBL] [Abstract][Full Text] [Related]
2. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy.
Kimura M; Caso JR; Bañez LL; Koontz BF; Gerber L; Senocak C; Donatucci CF; Vujaskovic Z; Moul JW; Polascik TJ
BJU Int; 2012 Dec; 110(11 Pt C):E931-8. PubMed ID: 22520165
[TBL] [Abstract][Full Text] [Related]
3. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
[TBL] [Abstract][Full Text] [Related]
4. The natural history of penile length after radical prostatectomy: a long-term prospective study.
Vasconcelos JS; Figueiredo RT; Nascimento FL; Damião R; da Silva EA
Urology; 2012 Dec; 80(6):1293-6. PubMed ID: 23102441
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy.
Kwon YS; Farber N; Yu JW; Rhee K; Han C; Ney P; Hong JH; Lee P; Gupta N; Kim WJ; Kim IY
BMC Urol; 2018 May; 18(1):37. PubMed ID: 29739455
[TBL] [Abstract][Full Text] [Related]
6. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy.
Köhler TS; Pedro R; Hendlin K; Utz W; Ugarte R; Reddy P; Makhlouf A; Ryndin I; Canales BK; Weiland D; Nakib N; Ramani A; Anderson JK; Monga M
BJU Int; 2007 Oct; 100(4):858-62. PubMed ID: 17822466
[TBL] [Abstract][Full Text] [Related]
7. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
Briganti A; Fabbri F; Salonia A; Gallina A; Chun FK; Dehò F; Zanni G; Suardi N; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2007 Sep; 52(3):702-7. PubMed ID: 17418936
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
[TBL] [Abstract][Full Text] [Related]
9. New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function.
Gontero P; Galzerano M; Bartoletti R; Magnani C; Tizzani A; Frea B; Mondaini N
J Urol; 2007 Aug; 178(2):602-7. PubMed ID: 17570431
[TBL] [Abstract][Full Text] [Related]
10. Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective.
Nelson CJ; Scardino PT; Eastham JA; Mulhall JP
J Sex Med; 2013 Jun; 10(6):1636-43. PubMed ID: 23551767
[TBL] [Abstract][Full Text] [Related]
11. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
Basal S; Wambi C; Acikel C; Gupta M; Badani K
BJU Int; 2013 Apr; 111(4):658-65. PubMed ID: 23186312
[TBL] [Abstract][Full Text] [Related]
12. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function.
Mulhall JP; Parker M; Waters BW; Flanigan R
BJU Int; 2010 Jan; 105(1):37-41. PubMed ID: 19659465
[TBL] [Abstract][Full Text] [Related]
13. Penile rehabilitation after radical prostatectomy: what the evidence really says.
Fode M; Ohl DA; Ralph D; Sønksen J
BJU Int; 2013 Nov; 112(7):998-1008. PubMed ID: 23826962
[TBL] [Abstract][Full Text] [Related]
14. Adherence and barriers to penile rehabilitation over 2 years following radical prostatectomy.
Albaugh J; Adamic B; Chang C; Kirwen N; Aizen J
BMC Urol; 2019 Oct; 19(1):89. PubMed ID: 31590638
[TBL] [Abstract][Full Text] [Related]
15. Penile length alterations following penile prosthesis surgery.
Deveci S; Martin D; Parker M; Mulhall JP
Eur Urol; 2007 Apr; 51(4):1128-31. PubMed ID: 17084508
[TBL] [Abstract][Full Text] [Related]
16. Robot assisted laparoscopic radical prostatectomy with maximal urethral length preservation technique preserves penile length.
Reddy BN; Razdan S; Razdan S
J Robot Surg; 2023 Aug; 17(4):1525-1530. PubMed ID: 36867324
[TBL] [Abstract][Full Text] [Related]
17. Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.
Kaiho Y; Yamashita S; Arai Y
Int J Urol; 2013 Mar; 20(3):285-9. PubMed ID: 23311962
[TBL] [Abstract][Full Text] [Related]
18. A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer.
Savoie M; Kim SS; Soloway MS
J Urol; 2003 Apr; 169(4):1462-4. PubMed ID: 12629384
[TBL] [Abstract][Full Text] [Related]
19. Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy.
Teloken PE; Nelson CJ; Karellas M; Stasi J; Eastham J; Scardino PT; Mulhall JP
BJU Int; 2013 Apr; 111(4):653-7. PubMed ID: 22758405
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase Type 5 Inhibitor Use Following Radical Prostatectomy is not Associated with an Increased Risk of Biochemical Recurrence.
Jo JK; Kim K; Lee SE; Lee JK; Byun SS; Hong SK
Ann Surg Oncol; 2016 May; 23(5):1760-7. PubMed ID: 26717939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
